BioCentury
ARTICLE | Company News

Paracelsian sales and marketing update

December 6, 1993 8:00 AM UTC

In Vivo-CDK determines whether a chemical is capable of converting normal cells into cancerous cells, PRLN said, by quantifying the amount of protein biomarker (cyclin-dependent kinases) in tissue. An...